Cargando…
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
BACKGROUND: COVID-19 sequelae can affect about 15% of patients with cancer who survive the acute phase of SARS-CoV-2 infection and can substantially impair their survival and continuity of oncological care. We aimed to investigate whether previous immunisation affects long-term sequelae in the conte...
Ejemplares similares
-
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
por: Pinato, David J, et al.
Publicado: (2022) -
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry
por: Cortellini, Alessio, et al.
Publicado: (2022) -
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
por: Cortellini, Alessio, et al.
Publicado: (2022) -
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
por: Pinato, David J., et al.
Publicado: (2022) -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
por: Garrigós, Laia, et al.
Publicado: (2021)